Insights and Analysis
Life Science Law Update – Key developments for pharma and device companies in EU and EU Big Five
31 January 2023
Mikael Salmela
PartnerParis
Email [email protected]hoganlovells.com
Phone +33 1 53 67 48 16
LanguagesEnglish, French, Finnish
Practice groupGlobal Regulatory
'Mikael Salmela is praised for his “very good understanding of how to combine the ‘academic’ laws, rules and regulations with the ‘practical’ questions we are facing in our day to day business”
Who's Who Legal, 2013
As a partner in the Hogan Lovells' Paris office and a member of our Corporate & Finance Commercial practice, Mikael focuses on commercial, regulatory and contractual work. Mikael has considerable experience dealing with a variety of complex and strategic agreements in various industry sectors, such as life sciences, energy and IT. Mikael's experience in regulatory matters covers a wide array of topics, including various consumer products and export controls, with a particular focus on life sciences.
Mikael has in-house counsel experience since he was seconded for several months to an online mass retailer of consumer products and to the French subsidiary of a U.S.-based pharmaceutical company. Mikael was also seconded to our London office for six months.
Awards and recognitions
2018-2020
Healthcare and life sciences (France), Recommended
Legal 500 EMEA
2019-2020
Acritas Star
Acritas Stars Independently Rated Lawyers
2020
Mikael Salmela: Recommended as a National Leader in Life Sciences
Who's Who Legal
2020
Mikael Salmela: Recommended as a Global Leader in Life Sciences: Regulatory
Who's Who Legal
2020
Mikael Salmela: Recommended as a Global Leader in Life Sciences: Transactional
Who's Who Legal
Education and admissions
Education
Magistère Juriste d'Affaires/ DJCE, University of Montpellier, 1999
Bar admissions and qualifications
Paris
Representative experience
Advises companies in life sciences industry on regulatory issues in lifecycle of products (marketing authorizations, classifications of products, advertising, anti-benefits regulations, and sunshine regulations).
Mikael regularly advises pharmaceutical and medical device companies on their joint development and co-marketing agreements with other industry players.
Advises leading energy company on drafting/negotiating several R&D consortium agreements involving multiple parties on EU subsidized pan-European projects relating to smart grids and electric vehicles.
Advises international groups in banking, pharmaceutical, power generation, hygiene, and security sectors, on drafting/negotiating agreements with outsourcing services providers in France and abroad.
Mikael advises a leading Asian oil and gas company in relation to production sharing contracts and joint operation agreements in Africa.
Mikael advises a leading resource group in relation to a procurement agreement for oilfield goods and services in North Africa.
Latest thinking and events
Webinar
Digital health: The key things insurers need to know
Wednesday, 8 February 2023 (11 a.m. ET / 4 p.m. GMT / 5 p.m. CET)
News
Can sterile drug manufacturers implement EU GMP Annex 1 requirements before August?
17 January 2023
News
Social Security Financing Law for 2023: a year-end gift for teleconsultation companies
03 January 2023
News
Online gaming regulatory practice in France - Part 1: T&C of video game digital distribution stores
15 December 2022
News
Teleconsultations in France: a (r)evolution coming for commercial companies?
07 November 2022
